Philipp A Ilinykh
Philipp A Ilinykh
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Kai Huang
Kai Huang
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Bronwyn M Gunn
Bronwyn M Gunn
3Ragon Institute of MGH, MIT and Harvard, Cambridge, MA USA
3,
Natalia A Kuzmina
Natalia A Kuzmina
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Kritika Kedarinath
Kritika Kedarinath
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Eduardo Jurado-Cobena
Eduardo Jurado-Cobena
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Fuchun Zhou
Fuchun Zhou
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Chandru Subramani
Chandru Subramani
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
1,2,
Matthew A Hyde
Matthew A Hyde
2Galveston National Laboratory, Galveston, TX USA
2,
Jalene V Velazquez
Jalene V Velazquez
4Paul G. Allen School of Global Health, Washington State University, Pullman, WA USA
4,
Lauren E Williamson
Lauren E Williamson
5Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN USA
5,
Pavlo Gilchuk
Pavlo Gilchuk
5Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN USA
5,
Robert H Carnahan
Robert H Carnahan
5Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN USA
6Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN USA
5,6,
Galit Alter
Galit Alter
3Ragon Institute of MGH, MIT and Harvard, Cambridge, MA USA
3,✉,
James E Crowe Jr
James E Crowe Jr
5Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN USA
6Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN USA
7Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN USA
5,6,7,✉,
Alexander Bukreyev
Alexander Bukreyev
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
8Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX USA
1,2,8,✉
1Department of Pathology, University of Texas Medical Branch, Galveston, TX USA
2Galveston National Laboratory, Galveston, TX USA
3Ragon Institute of MGH, MIT and Harvard, Cambridge, MA USA
4Paul G. Allen School of Global Health, Washington State University, Pullman, WA USA
5Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN USA
6Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN USA
7Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN USA
8Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX USA
Subject terms: Antibodies, Ebola virus, Complement cascade
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.